Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
---|---|---|---|---|---|---|---|
Oct 31, 2006 |
SVP, Therap & Clin Prog Dev
Trans History: 683
|
SVP, Therap & Clin Prog Dev | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 200 | $10.56 | 9,847 |
Oct 31, 2006 |
SVP, Therap & Clin Prog Dev
Trans History: 683
|
SVP, Therap & Clin Prog Dev | Form 4 | Open market or private sale of non-derivative or derivative security | 200 | $20.08 | 9,647 |
Oct 31, 2006 |
SVP, Therap & Clin Prog Dev
Trans History: 683
|
SVP, Therap & Clin Prog Dev | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 1,400 | $10.56 | 11,047 |
Oct 31, 2006 |
SVP, Therap & Clin Prog Dev
Trans History: 683
|
SVP, Therap & Clin Prog Dev | Form 4 | Open market or private sale of non-derivative or derivative security | 1,400 | $20.10 | 9,647 |
Oct 31, 2006 |
SVP, Therap & Clin Prog Dev
Trans History: 683
|
SVP, Therap & Clin Prog Dev | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 200 | $10.56 | 9,847 |
Oct 31, 2006 |
SVP, Therap & Clin Prog Dev
Trans History: 683
|
SVP, Therap & Clin Prog Dev | Form 4 | Open market or private sale of non-derivative or derivative security | 200 | $20.11 | 9,647 |
Oct 31, 2006 |
SVP, Therap & Clin Prog Dev
Trans History: 683
|
SVP, Therap & Clin Prog Dev | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 400 | $10.56 | 10,047 |
Oct 31, 2006 |
SVP, Therap & Clin Prog Dev
Trans History: 683
|
SVP, Therap & Clin Prog Dev | Form 4 | Open market or private sale of non-derivative or derivative security | 400 | $20.15 | 9,647 |
Oct 31, 2006 |
SVP, Therap & Clin Prog Dev
Trans History: 683
|
SVP, Therap & Clin Prog Dev | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 48 | $10.56 | 9,695 |
Oct 31, 2006 |
SVP, Therap & Clin Prog Dev
Trans History: 683
|
SVP, Therap & Clin Prog Dev | Form 4 | Open market or private sale of non-derivative or derivative security | 48 | $20.16 | 9,647 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.